Cycloadenosine meglumine injection

Cyclic adenosine monophosphate meglumine is a non-digitalis cardiotonic agent with a positive inotropic effect. It can enhance myocardial contractility, improve cardiac pumping function, dilate blood vessels, and reduce myocardial oxygen consumption. It can improve myocardial cell metabolism and protect ischemic and hypoxic myocardium. It can also improve the function of sinoatrial node P cells.

The main ingredient of this product is cycloadenosine glucamine.

This product is a colorless or almost colorless clear liquid.

It is used for heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy, and can also be used as an auxiliary treatment for arrhythmias.

Intravenous drip: dilute with 200-500 ml 5% glucose injection and then drip intravenously, once a day, 60-180 mg each time.

Occasionally, symptoms such as palpitations, heart palpitations, and dizziness may occur.

1. Those who are allergic to any ingredient in the drug. 2. This product is contraindicated for simultaneous intravenous administration with aminophylline.

This product is contraindicated for simultaneous intravenous administration with aminophylline.

Keep away from light and store in a sealed container.

2ml:30mg

30 months.

Jiangsu Kanion Pharmaceutical Co., Ltd.

• Founded in:

  1996-05-08

• Address:

  Lianyungang Economic and Technological Development Zone Jiangning Industrial City

• Tax NO.:

  91320700138997640W

• Registered Funds:

  581.797452 million yuan

• Website:

  Log in to view

• Email:

  Log in to view